 |
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE) |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2011-02-04 00:00:00 |
| Sponsor | Millennium Pharmaceuticals, Inc.;40 Landsdowne St.;Cambridge, Massachusetts, 02139 |
